Flexion Therapeutics Adds $20M

Woburn, Mass.-based Flexion Therapeutics Inc. has closed on $20 million in Series B financing. Novo Ventures, a new investor, led the round. Flexion's existing investors 5AM Ventures, Pfizer Venture Investments, Sofinnova Partners and Versant Ventures also participated. Proceeds will be used to fund late stage clinical development of the company's therapies for the treatment of osteoarthritis. Heath Lukatch, a partner in Novo Ventures, has joined the company's board.

North AmericaUSBriefs